ARO-RAGE

RAGE antagonist (inhaled) · Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARO-RAGE, covering 2026-04-09 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma [Phase 2]